Skin Cancer | Tumor

Treatment Challenges of laBCC

July 6th 2021, 1:59pm


Anna C. Pavlick, D.O., describes the various challenges health care providers may face when treating patients with locally advanced basal cell carcinoma (laBCC).

laBCC: Cemiplimab Safety Monitoring

July 6th 2021, 1:54pm


Insights into cemiplimab treatment monitoring and management in locally advanced basal cell carcinoma (laBCC).

Cemiplimab for Treatment of laBCC

July 6th 2021, 1:50pm


An expert discusses treatment options available for patients with locally advanced basal cell carcinoma (laBCC) who don’t respond or are intolerant to the first-line therapy option.

FDA Approves Keytruda for Locally Advanced Form of Skin Cancer

July 6th 2021, 12:12pm


The Food and Drug Administration (FDA) approved Keytruda (pembrolizumab) for the treatment of patients with locally advanced cutaneous squamous cell carcinoma (cSCC) that cannot be cured by surgery or radiation.

The Rise of a ‘Rare But Increasingly Common’ Skin Cancer

July 5th 2021, 3:00pm


As rates of merkel cell carcinoma increase, patients should be aware of the risk factors and symptoms of this skin cancer.

Being Proactive Against Skin Cancer

July 1st 2021, 9:00pm


After a previous diagnosis of skin cancer, patients are more likely to develop skin cancer lesions on the body. An expert gives helpful tips on what to look for and how to look for lesions to catch them early.

Early Detection and Treatment Is Key in Skin Cancer

June 30th 2021, 9:00pm


Patients with basal cell or cutaneous squamous cell carcinoma tend to have good outcomes when the disease is caught early. For those in later stages, new treatments bring hope and better prognoses.

First-Line Treatment Options for laBCC

June 29th 2021, 12:04pm


Anna C. Pavlick, DO, provides an overview of hedgehog inhibitors, a first-line treatment option for patients diagnosed with locally advanced basal cell carcinoma (laBCC).

Multidisciplinary Management of laBCC

June 29th 2021, 12:03pm


A discussion about multidisciplinary management of locally advanced basal cell carcinoma (laBCC) and how dermatologists and medical oncologists collaborate within the care of a patient.

laBCC: Skin Biopsy

June 29th 2021, 12:02pm


An expert discusses features of a skin lesion that would prompt a skin biopsy in the diagnosis of locally advanced basal cell carcinoma (laBCC).